Western blot analysis demonstrated that the CD133 and Nestin protein levels in CD133+ glioma stem cells were significantly higher than those in CD133- glioma cells, whereas the protein level of LASS2 in CD133+ glioma stem cells was significantly lower than that in CD133- glioma cells (Fig. 2E). This evidence concerns the gene NES and central nervous system cancer.